1995
DOI: 10.1111/j.1528-1157.1995.tb01649.x
|View full text |Cite
|
Sign up to set email alerts
|

Neurotransmission in Epilepsy

Abstract: Summary: Some evidence indicates that in some types of focal epilepsy the enhanced excitability is due in part to impaired γ‐aminobutyric acid (GABA)ergic inhibitory feedback. One form that this can take is impaired excitatory input to GABAergic interneurons. Enhanced excitatory receptor sensitivity, most characteristically involving N‐methyl‐D‐aspartate (NMDA) receptors, has been identified in kindled rodents and in focal epilepsy in humans. Drugs that enhance GABA‐mediated inhibition are anticonvulsant in m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
27
0
2

Year Published

1997
1997
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 72 publications
(29 citation statements)
references
References 66 publications
0
27
0
2
Order By: Relevance
“…A variety of clinical and experimental findings have suggested that functional impairment of the GABAergic systems plays a fundamental role in the etiology of epilepsy (21,22). Recent clinical studies conducted in patients with TLE demonstrated impairment of increase in extracellular GABA concentration in the epileptogenic HIPP during seizures (23).…”
Section: Discussionmentioning
confidence: 99%
“…A variety of clinical and experimental findings have suggested that functional impairment of the GABAergic systems plays a fundamental role in the etiology of epilepsy (21,22). Recent clinical studies conducted in patients with TLE demonstrated impairment of increase in extracellular GABA concentration in the epileptogenic HIPP during seizures (23).…”
Section: Discussionmentioning
confidence: 99%
“…Notably, CEP-26401 completed phase 1 of a clinical study addressing its pharmacokinetics and pharmacodynamics in healthy subjects for cognition and sleep-wake indications without disclosing the clinical outcomes of these studies (ClinicalTrials.gov trial registration number: NCT01903824) (Figure 10, Table 1&4). Of specific interest is pitolisant (also known as triprolisant) [30,[102][103][104] [30,[133][134][135] which is a potent H3R antagonist (Figure 10, Table 1) [102,[105][106][107]. Preclinically, pitolisant was shown to enhance dopamine and acetylcholine levels in microdialysates of the prefrontal cortex in rats [102].…”
Section: Alzheimer's Diseasementioning
confidence: 99%
“…Both BE and diazepam prevented the occurrence of lithium-pilocarpine induced seizures (Sherman, 1991). Since epilepsy is linked to low GABA levels in the brain (Meldrum, 1995), the effect of the BE on the brain content of GABA was investigated. An increase in the GABA content of the brain was observed and this could be the likely mechanism of anticonvulsant action of BE, as drugs increasing GABAergic transmission inhibit seizures (Gupta and Malhotra, 1997;Rang et al, 1999).…”
Section: Discussionmentioning
confidence: 99%